Connor, Clark & Lunn Investment Management (CC&L)’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,456	Closed	-$750K	–	1166
2021 Q1	$750K	Buy	+3,456	New	+$650K	﹤0.01%	737

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s GWPH Position: Q2 2021 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 3,456 shares — an estimated $750K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in GWPH in Q1 2021 and held it in 1 quarter. The position peaked at $750K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 3,456 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $750K.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2021 and held it in 1 quarter.
Connor, Clark & Lunn Investment Management (CC&L)'s GW Pharmaceuticals Plc American Depositary Shares position peaked at $750K in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2021, filed 12 Aug 2021.